drugset / Trial / NCT01445782

AZD2115 Multiple Ascending Dose Study

NCT01445782

Phase 1 Completed 32 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindBasic science

Summary

This study will investigate the safety and tolerability of AZD2115 following administration of multiple ascending doses.

Timeline

Start
2011-10
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD2115 Unknown Inhaled

Indications

No indication recorded.